BioSyent Inc. (TSXV:RX)
Canada · Delayed Price · Currency is CAD 15.75
-0.20 (-1.25%)
Aug 28, 2026, 3:50 PM EST
BioSyent Market Cap
BioSyent has a market cap or net worth of CAD 178.11 million as of August 28, 2026. Its market cap has increased by 30.72% in one year.
Market Cap
178.11M
Enterprise Value
172.31M
Revenue
55.67M
Ranking
n/a
PE Ratio
18.44
Stock Price
15.75
ChartMarket Cap Chart
Since April 24, 1997, BioSyent's market cap has increased from 13.21M to 178.11M, an increase of 1,248.77%. That is a compound annual growth rate of 9.26%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 178.11M | 24.23% |
| Dec 31, 2025 | 143.37M | 12.27% |
| Dec 31, 2024 | 127.69M | 17.76% |
| Dec 29, 2023 | 108.44M | 28.05% |
| Dec 30, 2022 | 84.69M | -18.50% |
| Dec 30, 2021 | 103.91M | 2.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cipher Pharmaceuticals | 359.88M |
| Cardiol Therapeutics | 335.28M |
| Auxly Cannabis Group | 325.19M |
| TerrAscend | 268.98M |
| Organigram Global | 236.50M |
| Cannara Biotech | 197.56M |
| Medexus Pharmaceuticals | 162.79M |
| Grown Rogue International | 157.46M |